BioCentury
ARTICLE | Clinical News

PharmaMar starts liver cancer Phase II

May 30, 2003 7:00 AM UTC

PharmaMar (Madrid, Spain) began a Phase II trial of its Kahalalide F to treat advanced liver cancer. The compound is derived from a sea slug and alters the function of the lysosomal membrane, the comp...